CRSP logo

Combined Holdings of CRSP in All ARK ETFs

CRISPR Therapeutics

CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat various genetic diseases. The company generates revenue through partnerships, licensing agreements, and potentially through the commercialization of its therapeutic products once they receive regulatory approval.

Trades of CRSP in All Ark ETFs

The ten most recent trades of CRISPR Therapeutics in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Jan 17, 2025Buy$5,153,2901.95%0.08%
Jan 17, 2025Buy$5,153,2901.95%0.08%
Jan 17, 2025Buy$5,153,2901.95%0.08%
Jan 17, 2025Buy$890,9301.18%0.08%
Jan 17, 2025Buy$890,9301.18%0.08%
Jan 17, 2025Buy$890,9301.18%0.08%
Jan 16, 2025Buy$795,3111.09%0.07%
Jan 16, 2025Buy$4,516,4041.78%0.07%
Dec 27, 2024Buy$576,6490.79%0.05%
Dec 27, 2024Buy$3,422,7591.36%0.05%